Project Grant R21NS142656
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$447K
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a 5-year, $453,104 Project Grant (CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders) to The University of Texas Southwestern Medical Center. The grant will fund research to explore the role of two key subtypes of spinal projection neurons, TACR1-expressing and GPR83-expressing neurons, in transmitting pain signals to the brain and their potential as therapeutic targets for...
This $415,519 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the role of the SCN1B gene in susceptibility to neuropathic pain. The central hypothesis is that SCN1B, which encodes a key regulator of neuronal excitability, plays a critical part in the development of tactile allodynia in mouse models of neuropathic pain. The research will utilize a combination of...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $441,500 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Duquesne University of the Holy Spirit. The purpose of this 3-year grant, beginning September 2023, is to utilize laboratory data and computational 3-D modeling to analyze the role of the central amygdala in neuropathic pain. Specifically, the project aims to build a proof-of-concept 3-D...
This $1,511,970 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of selective GPR34 antagonists for the treatment of neuropathic pain. The research aims to identify CNS-penetrant GPR34 antagonists as potential non-opioid-based therapeutics for neuropathic pain, which affects 15-20 million people in the U.S. and has limited effective treatments. The project...
This federal Project Grant award, valued at $597,999.00 and issued by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research by the University of Pittsburgh focused on understanding the neuronal populations and central sensitization mechanisms underlying mechanical allodynia, a common and debilitating condition in which normally innocuous touch or...
This $650,079 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the development and optimization of novel small-molecule probes targeting alpha9-containing nicotinic acetylcholine receptors (α9*-nAChRs) for the treatment of chronic inflammatory and neuropathic pain. The 5-year research project, awarded to Northeastern University,...
The federal Project Grant award R01NS136997, totaling $560,934.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award aims to define the temporal patterns and characteristics of local field potential (LFP) oscillations in the primary somatosensory cortex (S1) of mice, and correlate these LFP oscillations to underlying neural activity and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,370,000 to develop advanced human pluripotent stem cell (HPSC) tools to create comprehensive and region-specific models for studying pain circuitry. The primary objectives are to: Develop scalable methods to generate region-specific sensory neurons and glial subtypes, Create and characterize region-specific...
This $5,037,022 project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will support the development of novel single-cell technologies called "Raman2omics" to map pain-associated genes and cells across the lifespan. Funded under the Drug Abuse and Addiction Research Programs, the grant to the Massachusetts General Hospital aims to apply Raman2omics to systematically investigate genes and cells associated with postoperative pain...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $499,979 to The Salk Institute for Biological Studies to conduct research aimed at uncovering the role of astrocytes, a type of glial cell, in neuropathic pain pathology. The project seeks to 1) determine how peripheral nerve injury alters dorsal horn astrocyte function, 2)...